EcoDrugPlus

Ensembl ID : ENSACIG00000010621
Gene Symbol: -
Cross references: -
194 Possible Orthologues:

Ensembl ID : ENSACIG00000018503
Gene Symbol: -
Cross references: -
207 Possible Orthologues:

Ensembl ID : ENSACIG00000006585
Gene Symbol: -
Cross references: -
209 Possible Orthologues:

Ensembl ID : ENSACIG00000002154
Gene Symbol: TTK
1 Cross references
204 Possible Orthologues:

Ensembl ID : ENSACIG00000015896
Gene Symbol: -
Cross references: -
212 Possible Orthologues:

Ensembl ID : ENSACIG00000005441
Gene Symbol: -
Cross references: -
195 Possible Orthologues:

Ensembl ID : ENSACIG00000020436
Gene Symbol: -
Cross references: -
213 Possible Orthologues:

Ensembl ID : ENSACIG00000005876
Gene Symbol: -
Cross references: -
213 Possible Orthologues:

Ensembl ID : ENSACIG00000020210
Gene Symbol: -
Cross references: -
213 Possible Orthologues:

Ensembl ID : ENSACIG00000008034
Gene Symbol: -
Cross references: -
214 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).